Abstract
An analysis has been made of the clinical prognostic factors of localised prostatic cancer (stages A, B and C) in 108 patients, who underwent radical prostatectomy and have a recorded follow-up. Results show that age, urological symptoms, performance status and basal testosterone cannot be used for prognosis. Only creatinine, among the biohumoral tests, was at a statistically significant level, which could be explained by obstructions during progression of the disease. This study has shown that PSA can be considered of prognostic value and can be correlated to the clinical and pathological stage; it is predictive in stage C with basal PSA > 10. The volume of the primitive neoplasm related to the T category gives both a clinical and histopathological classification; local extension of the disease is a significant clinical factor. Lastly, grading according to Mostofi indicates progression of disease in direct proportion to the degree of differentiation.
Get full access to this article
View all access options for this article.